The FDA cleared Awiqli as the first weekly insulin for kids 10 and up with type 2 diabetes, and a CagriSema subgroup showed 25% weight loss in women.
Recap by typeshit. Full story at ad-hoc-news.de.
The Illinois governor is speaking openly about his own GLP-1 use, saying he wants to end the stigma around the drugs. The post comes from a political fan page on Facebook.
Trell argues a toned lower body comes from lean muscle, crediting weekly strength training and recovery fuel rather than Ozempic or peptides.
A rundown on the pill version of Wegovy, covering what form it comes in and its availability. Thin on details, so tap through for the specifics.
No weigh-in this time, just a personal check-in saying the journey is going well so far, plus one thing they've noticed along the way.
The review looks at concerns about misuse as demand for GLP-1 drugs grows, and points to how little evidence guides their use beyond approved conditions.
Researchers found self-reported GLP-1 use climbed from March 2024 to October 2025, mostly for weight loss, through channels insurance data may not capture.
Loading…